VAST评分对肝细胞癌右半肝切除术后显著性肝衰竭的预测价值研究
Research on the Predictive Value of VAST Score for Significant Liver Failure after Right Hemihepatectomy for Hepatocellular Carcinoma
DOI: 10.12677/acm.2025.1582235, PDF,    科研立项经费支持
作者: 张玉敏, 罗宁斌*:广西医科大学附属肿瘤医院影像科,广西 南宁;高军平:广西医科大学附属肿瘤医院肝胆外科,广西 南宁
关键词: 肝细胞癌肝功能衰竭危险因素列线图预测模型Hepatocellular Carcinoma Liver Failure Risk Factors Nomogram Prediction Model
摘要: 目的:探讨VAST评分对肝细胞癌右半肝切除术后显著性肝衰竭的预测价值。方法:回顾性分析206例行右半肝切除术的肝细胞癌患者的临床资料。通过单多因素Logistic回归分析确定肝细胞癌右半肝切除术后显著肝功能衰竭的独立预测因素,并建立列线图模型,采用Bootstrap等量有放回重复抽样1000次的方法进行内部验证。绘制受试者工作特征曲线(ROC曲线)、校准曲线、决策曲线评估模型性能,并与传统评分模型的预测效能进行对比。结果:多因素Logistic回归分析显示,VAST评分 ≥ 2分(OR= 4.480, P = 0.018)、残肝体积体重比降低(OR = 0.034, P = 0.004)、MELD评分增加(OR = 1.775, P = 0.001)是肝细胞癌右半肝切除术后显著肝功能衰竭的独立预测因素。列线图模型的受试者工作特征曲线下面积(AUC)为0.772,校准能力良好。通过比较ROC及临床决策曲线发现,列线图模型的预测效能和临床决策效益优于传统评分模型。结论:基于VAST评分 ≥ 2分、残肝体积体重比和MELD评分构建的列线图模型在预测肝细胞癌右半肝切除术后显著性肝衰竭方面具有一定的价值。
Abstract: Objective: To explore the predictive value of the VAST score for significant liver failure after right hemihepatectomy for hepatocellular carcinoma. Methods: The clinical data of 206 patients with hepatocellular carcinoma who underwent right hemihepatectomy were retrospectively analyzed. Univariate and multivariate Logistic regression analyses were used to determine the independent predictors of significant liver failure after right hemihepatectomy for hepatocellular carcinoma, and a nomogram model was established. Internal validation was performed using the Bootstrap method with 1000 repeated samplings. The performance of the model was evaluated by drawing the receiver operating characteristic curve (ROC curve), calibration curve, and decision curve, and compared with the predictive efficacy of traditional scoring models. Results: Multivariate Logistic regression analysis showed that a VAST score ≥ 2 (OR = 4.480, P = 0.018), a decreased ratio of residual liver volume to body weight (OR = 0.034, P = 0.004), and an increased MELD score (OR = 1.775, P = 0.001) were independent predictors of significant liver failure after right hemihepatectomy for hepatocellular carcinoma. The area under the ROC curve (AUC) of the nomogram model was 0.772, and the calibration ability was good. By comparing the ROC and clinical decision curves, it was found that the predictive efficacy and clinical decision-making benefits of the nomogram model were superior to those of traditional scoring models. Conclusion: The nomogram model based on a VAST score ≥ 2, the ratio of residual liver volume to body weight, and the MELD score has certain value in predicting significant liver failure after right hemihepatectomy for hepatocellular carcinoma.
文章引用:张玉敏, 高军平, 罗宁斌. VAST评分对肝细胞癌右半肝切除术后显著性肝衰竭的预测价值研究[J]. 临床医学进展, 2025, 15(8): 306-317. https://doi.org/10.12677/acm.2025.1582235

参考文献

[1] Dopazo, C., Søreide, K., Rangelova, E., Mieog, S., Carrion-Alvarez, L., Diaz-Nieto, R., et al. (2024) Hepatocellular Carcinoma. European Journal of Surgical Oncology, 50, Article ID: 107313. [Google Scholar] [CrossRef] [PubMed]
[2] Kauffmann, R. and Fong, Y. (2014) Posthepatectomy Liver Failure. Hepatobiliary Surgery and Nutrition, 3, 238-246.
[3] Søreide, J.A. and Deshpande, R. (2021) Post Hepatectomy Liver Failure (PHLF)—Recent Advances in Prevention and Clinical Management. European Journal of Surgical Oncology, 47, 216-224. [Google Scholar] [CrossRef] [PubMed]
[4] Baumgartner, R., Gilg, S., Björnsson, B., Hasselgren, K., Ghorbani, P., Sauter, C., et al. (2022) Impact of Post-Hepatectomy Liver Failure on Morbidity and Short-and Long-Term Survival after Major Hepatectomy. BJS Open, 6, zrac097.
[5] Kang, C.M., Ku, H.J., Moon, H.H., Kim, S., Jo, J.H., Choi, Y.I., et al. (2024) Predicting Safe Liver Resection Volume for Major Hepatectomy Using Artificial Intelligence. Journal of Clinical Medicine, 13, Article 381. [Google Scholar] [CrossRef] [PubMed]
[6] Lei, Z., Cheng, N., Si, A., Yang, P., Guo, G., Ma, W., et al. (2022) A Novel Nomogram for Predicting Postoperative Liver Failure after Major Hepatectomy for Hepatocellular Carcinoma. Frontiers in Oncology, 12, Article 817895. [Google Scholar] [CrossRef] [PubMed]
[7] Wang, J.J., Feng, J., Gomes, C., Calthorpe, L., Ashraf Ganjouei, A., Romero-Hernandez, F., et al. (2023) Development and Validation of Prediction Models and Risk Calculators for Posthepatectomy Liver Failure and Postoperative Complications Using a Diverse International Cohort of Major Hepatectomies. Annals of Surgery, 278, 976-984. [Google Scholar] [CrossRef] [PubMed]
[8] Allaire, M., Goumard, C., Lim, C., Le Cleach, A., Wagner, M. and Scatton, O. (2020) New Frontiers in Liver Resection for Hepatocellular Carcinoma. JHEP Reports, 2, Article ID: 100134. [Google Scholar] [CrossRef] [PubMed]
[9] Li, Y.R., Chen, J.D., Huang, J., et al. (2022) Post-Hepatectomy Liver Failure Prediction and Prevention: Development of a Nomogram Containing Postoperative Anticoagulants as a Risk Factor. Annals of Hepatology, 27, Article ID: 100744. [Google Scholar] [CrossRef] [PubMed]
[10] Ye, J.Z., Lu, H.Z., Zeng, C., et al. (2024) A Novel Surgical Scheme for Hepatectomy in Hepatocellular Carcinoma Patients with Clinically Significant Portal Hypertension. BMC Cancer, 24, Article No. 764. [Google Scholar] [CrossRef] [PubMed]
[11] EOF Research (2012) EASL-EORTC Clinical Practice Guidelines: Management of Hepatocellular Carcinoma. European Journal of Cancer, 48, 599-641.
[12] Marrero, J.A., Kulik, L.M., Sirlin, C.B., Zhu, A.X., Finn, R.S., Abecassis, M.M., et al. (2018) Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases. Hepatology, 68, 723-750. [Google Scholar] [CrossRef] [PubMed]
[13] Elder, R.W., McCabe, N.M., Hebson, C., Veledar, E., Romero, R., Ford, R.M., et al. (2013) Features of Portal Hypertension Are Associated with Major Adverse Events in Fontan Patients: The VAST Study. International Journal of Cardiology, 168, 3764-3769. [Google Scholar] [CrossRef] [PubMed]
[14] Zafar, F., Lubert, A.M., Trout, A.T., Katz, D.A., Palermo, J.J., Opotowsky, A.R., et al. (2022) Abdominal CT and MRI Findings of Portal Hypertension in Children and Adults with Fontan Circulation. Radiology, 303, 557-565. [Google Scholar] [CrossRef] [PubMed]
[15] Johnson, P.J., Berhane, S., Kagebayashi, C., Satomura, S., Teng, M., Reeves, H.L., et al. (2015) Assessment of Liver Function in Patients with Hepatocellular Carcinoma: A New Evidence-Based Approach—The ALBI Grade. Journal of Clinical Oncology, 33, 550-558. [Google Scholar] [CrossRef] [PubMed]
[16] Freeman, R.B. (2008) Model for End-Stage Liver Disease (MELD) for Liver Allocation: A 5-Year Score Card. Hepatology, 47, 1052-1057. [Google Scholar] [CrossRef] [PubMed]
[17] Sonneveld, M.J., Brouwer, W.P., Chan, H.L., Piratvisuth, T., Jia, J., Zeuzem, S., et al. (2019) Optimisation of the Use of APRI and FIB-4 to Rule Out Cirrhosis in Patients with Chronic Hepatitis B: Results from the SONIC-B Study. The Lancet Gastroenterology & Hepatology, 4, 538-544. [Google Scholar] [CrossRef] [PubMed]
[18] Rahbari, N.N., Garden, O.J., Padbury, R., Brooke-Smith, M., Crawford, M., Adam, R., et al. (2011) Posthepatectomy Liver Failure: A Definition and Grading by the International Study Group of Liver Surgery (ISGLS). Surgery, 149, 713-724. [Google Scholar] [CrossRef] [PubMed]
[19] Simonetto, D.A., Liu, M. and Kamath, P.S. (2019) Portal Hypertension and Related Complications: Diagnosis and Management. Mayo Clinic Proceedings, 94, 714-726. [Google Scholar] [CrossRef] [PubMed]
[20] Kim, M.Y., Baik, S.K. and Lee, S.S. (2010) Hemodynamic Alterations in Cirrhosis and Portal Hypertension. The Korean Journal of Hepatology, 16, 347-352. [Google Scholar] [CrossRef] [PubMed]
[21] Wang, J., Zhang, Z., Shang, D., Liao, Y., Yu, P., Li, J., et al. (2022) A Novel Nomogram for Prediction of Post-Hepatectomy Liver Failure in Patients with Resectable Hepatocellular Carcinoma: A Multicenter Study. Journal of Hepatocellular Carcinoma, 9, 901-912. [Google Scholar] [CrossRef] [PubMed]
[22] 马帅, 赵卫, 刘敏, 等. 基于四维血流磁共振成像的肝硬化门静脉血流动力学研究[J]. 临床放射学杂志, 2025, 44(3): 465-471.
[23] Iwakiri, Y. (2014) Pathophysiology of Portal Hypertension. Clinics in Liver Disease, 18, 281-291. [Google Scholar] [CrossRef] [PubMed]
[24] Seo, Y.S. and Shah, V.H. (2012) The Role of Gut-Liver Axis in the Pathogenesis of Liver Cirrhosis and Portal Hypertension. Clinical and Molecular Hepatology, 18, 337-346. [Google Scholar] [CrossRef] [PubMed]
[25] 闫雨竹, 边杰. 基于增强CT的非侵入性成像标志物在预测肝硬化患者肝脏相关事件中的研究进展[J]. 临床放射学杂志, 2022, 41(11): 2142-2145.
[26] Navarro, J.G., Yang, S.J., Kang, I., Choi, G.H., Han, D.H., Kim, K.S., et al. (2020) What Are the Most Important Predictive Factors for Clinically Relevant Posthepatectomy Liver Failure after Right Hepatectomy for Hepatocellular Carcinoma? Annals of Surgical Treatment and Research, 98, 62-71. [Google Scholar] [CrossRef] [PubMed]
[27] Lens, S., Rincón, D., García-Retortillo, M., Albillos, A., Calleja, J.L., Bañares, R., et al. (2015) Association between Severe Portal Hypertension and Risk of Liver Decompensation in Patients with Hepatitis C, Regardless of Response to Antiviral Therapy. Clinical Gastroenterology and Hepatology, 13, 1846-1853. [Google Scholar] [CrossRef] [PubMed]
[28] Yugawa, K., Maeda, T., Nagata, S., Shiraishi, J., Sakai, A., Yamaguchi, S., et al. (2022) Impact of Aspartate Aminotransferase-to-Platelet Ratio Index Based Score to Assess Posthepatectomy Liver Failure in Patients with Hepatocellular Carcninoma. World Journal of Surgical Oncology, 20, Article No. 248. [Google Scholar] [CrossRef] [PubMed]
[29] Cucchetti, A., Ercolani, G., Vivarelli, M., Cescon, M., Ravaioli, M., La Barba, G., et al. (2006) Impact of Model for End-Stage Liver Disease (MELD) Score on Prognosis after Hepatectomy for Hepatocellular Carcinoma on Cirrhosis. Liver Transplantation, 12, 966-971. [Google Scholar] [CrossRef] [PubMed]